Electro-medical safety tester meets new IEC 62353 standard

Rigel Medical, part of the Seaward Group, has launched a new biomedical electrical safety analyser.

Photo: Electro-medical safety tester meets new IEC 62353 standard

The Rigel 288 which meets the IEC 60601, and the forthcoming IEC 62353 in service test standard for electromedical equipment. ‘The ergonomically designed, hand-held safety tester combines innovative lightweight design and advanced test technology with a range of special features including battery power, blue tooth connection for data transfer and a menu driven easy to operate user interface.’

The analyser provides automatic, semi-automatic or fully manual electrical safety testing of all electromedical equipment. Importantly, preset or customised test programmes can also be selected to enable users to comply with individual, local or international standards outside the scope of IEC 62353 and IEC 60601 to provide fast and efficient testing of medical equipment with up to 10 individual patient connections or applied parts, Rigel adds. ‘The instrument’s internal memory can be used to store details of test results for transfer to a PC database, alongside user defined inspections and checks on such equipment as SpO2, NIBP, ECG and other electromedical equipment.’

This, with the Rigel 277 and Rigel 266 and Rigel 300 series (which includes a range of testers to verify the functionality of NIBP testers, pulse oximetry analysers, ventilators and defibrillators) and the company’s other test equipment, are on show at MEDICA.
Hall 11. Stand G48

14.11.2006

More on the subject:

Related articles

Photo

News • Mechanical stress-induced tissue remodelling

How asthma permanently alters the airways

Asthma attacks induce mechanical forces that permanently alter airway tissue – independently of inflammation. New research used advanced lung-on-a-chip technology to show how this damage occurs.

Photo

News • CRISPR-Cas9-based approach

New laboratory tool to find better treatments for resistant melanomas

Researchers have developed a new lab model to study BAP1-deficient melanomas, a rare type of melanoma that evade the immune system once they metastasize and are resistant to current immunotherapies.

Photo

News • Treatment-resistant tumours

Researchers tear off "invisibility cloak" of colon cancer

A study from the University of Calgary shows that removing a single gene makes colon cancer cells a target for immunotherapy — a fundamental breakthrough.

Subscribe to Newsletter